Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 2/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | BAX | Q07812 | 1/20 | 0.43 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 4/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TSPO | P30536 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30358267 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TRPA1LTA4HNR1H2BAX | |
| SCHEMBL10981342 | 0.86 | ALDH1A1 (0.48) | ALDH1A1TRPA1GAAHPGDKDM4E | |
| SCHEMBL23263220 | 0.85 | GAA (0.44) | ALDH1A1CTNNB1GAAKDM4EHSD17B10 | |
| SCHEMBL2916124 | 0.85 | LTA4H (0.52) | ALDH1A1LTA4HNR1H2BAXCTNNB1 | |
| SCHEMBL921819 | 0.85 | ALDH1A1 (0.62) | ALDH1A1TRPA1HPGDKDM4EHSD17B10 | |
| SCHEMBL11124182 | 0.83 | HTR2A (0.45) | ALDH1A1TRPA1KDM4EHTTL3MBTL1 | |
| SCHEMBL15011665 | 0.83 | LPAR1 (0.54) | ALDH1A1GAAHPGDKDM4EHSD17B10 | |
| SCHEMBL396882 | 0.81 | ALDH1A1 (0.52) | ALDH1A1LTA4HNR1H2BAXCTNNB1 | |
| SCHEMBL232763 | 0.81 | SMN1; SMN2 (0.56) | ALDH1A1LTA4HCTNNB1GAAHPGD | |
| SCHEMBL11125532 | 0.80 | SLC6A4 (0.50) | ALDH1A1L3MBTL1SLC6A2SLC6A4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| CN-118076767-A | Method and formulation for producing an optical metal oxide layer | 默克专利有限公司 | 2024-05-24 | — | — | CN | disclosed |
| WO-2023057401-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2023-04-13 | — | — | WO | disclosed |
| EP-2110370-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-1348686-B1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL CO (JP) | 2010-03-03 | — | — | EP | disclosed |
| EP-2110370-A1 | Method of producing p-hydroxyphenylalkanols | Sumitomo Chemical Company, Limited (JP) | 2009-10-21 | — | — | EP | disclosed |
| US-20080312349-A1 | METHOD OF MAKING AND USING MEMBRANE | GENERAL ELECTRIC COMPANY (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080207822-A1 | COMPOSITION AND ASSOCIATED METHOD | GENERAL ELECTRIC COMPANY (US) | 2008-08-28 | — | — | US | disclosed |
| WO-2008103599-A2 | COMPOSITION, ITS USE IN THE PREPARATION OF MEMBRANES, AND SYSTEMS COMPRISING THE MEMBRANES | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2008-08-28 | — | — | WO | disclosed |
| US-20080203012-A1 | MEMBRANE, APPARATUS, AND ASSOCIATED METHOD | GENERAL ELECTRIC COMPANY (US) | 2008-08-28 | — | — | US | disclosed |
| US-6717020-B2 | HIGH YIELD REACTION OF PHENOLS AND UNSATURATED ALCOHOLS IN PRESENCE OF SUCH AS TITANIUM TETRAETHOXIDE AND SODIUM METHOXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-04-06 | — | — | US | disclosed |
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-10-16 | — | — | US | disclosed |
| EP-1348686-A1 | Method of producing p-hydroxyphenylalkanols | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-10-01 | — | — | EP | disclosed |
| US-4367238-A | ANTIINFLAMMATORY AGENTS, ANALGESICS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1983-01-04 | — | — | US | disclosed |
| EP-0033614-A1 | Phenylalkanoic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030195379-A1 | Method of producing p-Hydroxyphenylalkanols | ADH1C, NR1H3, ADH5 | ALDH1A1 135/4885TRPA1 1518/4885LTA4H 885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.